Myrexis (FRA:R9M) Change In Payables And Accrued Expense : €-1.70 Mil (TTM As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Myrexis Change In Payables And Accrued Expense?

Myrexis's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2013 was €-0.21 Mil. It means Myrexis's Accounts Payable & Accrued Expense declined by €0.21 Mil from Mar. 2013 to Jun. 2013 .

Myrexis's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2013 was €-1.67 Mil. It means Myrexis's Accounts Payable & Accrued Expense declined by €1.67 Mil from Jun. 2012 to Jun. 2013 .

Myrexis Change In Payables And Accrued Expense Historical Data

The historical data trend for Myrexis's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myrexis Change In Payables And Accrued Expense Chart

Myrexis Annual Data

Trend

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-18.41

-0.27

-0.65

-0.82

-1.67

Myrexis Quarterly Data
	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-2.64	-0.59	-0.16	-0.74	-0.21

Myrexis Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.70 Mil.

Myrexis Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Myrexis's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Myrexis (FRA:R9M) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Myrexis Inc (FRA:R9M) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

630 Fifth Avenue, Suite 2260, New York, NY, USA, 10020

Website

http://www.myrexis.com

Myrexis Inc is engaged in evaluating strategic alternatives, such as identifying, evaluating and making financial investments in life sciences assets.

Myrexis (FRA:R9M) Headlines

No Headlines